Molecular mechanisms for tumour resistance to chemotherapy
ST Pan, ZL Li, ZX He, JX Qiu… - Clinical and Experimental …, 2016 - Wiley Online Library
Chemotherapy is one of the prevailing methods used to treat malignant tumours, but the
outcome and prognosis of tumour patients are not optimistic. Cancer cells gradually …
outcome and prognosis of tumour patients are not optimistic. Cancer cells gradually …
Advances in sarcoma gene mutations and therapeutic targets
P Gao, NA Seebacher, F Hornicek, Z Guo… - Cancer treatment …, 2018 - Elsevier
Sarcomas are rare and complex malignancies that have been associated with a poor
prognostic outcome. Over the last few decades, traditional treatment with surgery and/or …
prognostic outcome. Over the last few decades, traditional treatment with surgery and/or …
Primary cardiac angiosarcoma: a case report
X Fang, S Zheng - Journal of International Medical Research, 2021 - journals.sagepub.com
Primary cardiac angiosarcoma is relatively rare, and most cases involve metastasis at the
time of diagnosis. The median survival time is 14 months for patients who can be treated …
time of diagnosis. The median survival time is 14 months for patients who can be treated …
The cell uptake properties and hyperthermia performance of Zn0.5Fe2.5O4/SiO2 nanoparticles as magnetic hyperthermia agents
R Wang, J Liu, Y Liu, R Zhong, X Yu… - Royal Society …, 2020 - royalsocietypublishing.org
Zn0. 5Fe2. 5O4 nanoparticles (NPs) of 22 nm are synthesized by a one-pot approach and
coated with silica for magnetic hyperthermia agents. The NPs exhibit superparamagnetic …
coated with silica for magnetic hyperthermia agents. The NPs exhibit superparamagnetic …
[HTML][HTML] Poly (ethylene glycol)-sheddable reduction-sensitive polyurethane micelles for triggered intracellular drug delivery for osteosarcoma treatment
Background The survival rate of osteosarcoma therapy still lags behind overall cancer
therapies due to the intrinsic or acquired drug resistance. Developing novel drug delivery …
therapies due to the intrinsic or acquired drug resistance. Developing novel drug delivery …
Pazopanib and trametinib as a synergistic strategy against osteosarcoma: Preclinical activity and molecular insights
G Chiabotto, G Grignani, M Todorovic, V Martin… - Cancers, 2020 - mdpi.com
Receptor tyrosine kinases (RTKs) inhibitors' activity in advanced osteosarcoma is significant
but short-lived. To prevent or at least delay drug resistance, we explored a vertical inhibition …
but short-lived. To prevent or at least delay drug resistance, we explored a vertical inhibition …
Euphorbia lunulata extract acts on multidrug resistant gastric cancer cells to inhibit cell proliferation, migration and invasion, arrest cell cycle progression, and induce …
Z Fu, X Han, J Du, X Han, W Liu, S Shao… - Journal of …, 2018 - Elsevier
Ethnopharmacological relevance The milky sap or the aboveground part of the plant
Euphorbia lunulata has long been used by Chinese people to treat noncancerous growths …
Euphorbia lunulata has long been used by Chinese people to treat noncancerous growths …
A novel case of an aggressive superficial spindle cell sarcoma in an adult resembling fibrosarcomatous dermatofibrosarcoma protuberans and harboring an EML4 …
A subset of soft tissue sarcomas often harbors recurrent fusions involving protein kinases.
While some of these fusion events have shown utility in arriving at a precise diagnosis, novel …
While some of these fusion events have shown utility in arriving at a precise diagnosis, novel …
Research Progress on Chemical Constituents and Anticancer Pharmacological Activities of Euphorbia lunulata Bunge
Y Wang, X Yu, L Wang, F Zhang… - BioMed Research …, 2020 - Wiley Online Library
Euphorbia lunulata Bunge (ELB) is a traditional Chinese medicine possessing the functions
of expectoration, cough relief, asthma relief, detoxification, and itching relief. Modern …
of expectoration, cough relief, asthma relief, detoxification, and itching relief. Modern …
Transcriptome and Functional Genomics Reveal the Participation of Adenine Phosphoribosyltransferase in Trypanosoma cruzi Resistance to Benznidazole
P García‐Huertas, AM Mejía‐Jaramillo… - Journal of Cellular …, 2017 - Wiley Online Library
Currently, the only available treatments for Trypanosoma cruzi are benznidazole (Bz) and
nifurtimox (Nfx). The mechanisms of action and resistance to these drugs in this parasite are …
nifurtimox (Nfx). The mechanisms of action and resistance to these drugs in this parasite are …